Cancer Biology and Therapeutics (ICCBT-27)

This track will explore the mechanisms by which tumor suppressor genes contribute to cancer development and progression. Discussions will include recent discoveries and their implications for therapeutic strategies.

Focusing on the role of protein kinases in cellular signaling pathways, this track will address their significance in cancer biology. Participants will examine how aberrations in these pathways can lead to tumorigenesis.

This session will delve into the interactions between steroids and their receptors, highlighting their influence on cancer cell behavior. The implications for targeted therapies and treatment resistance will also be discussed.

This track will present the latest advancements in the use of transgenic mice for studying cancer biology. Participants will discuss the advantages and challenges of these models in preclinical research.

Exploring the intricate relationship between apoptosis and cancer, this session will highlight novel therapeutic targets aimed at restoring apoptotic pathways. The potential for enhancing cancer treatment through apoptosis modulation will be emphasized.

This track will focus on the application of RNA interference as a therapeutic strategy in cancer treatment. Participants will discuss recent advancements and challenges in translating RNAi technology into clinical practice.

This session will investigate the role of viral infections in cancer development and their potential as therapeutic agents. Discussions will include oncolytic viruses and their application in targeted cancer therapies.

Focusing on the molecular mechanisms underlying carcinogenesis and mutagenesis, this track will explore how genetic and environmental factors contribute to cancer initiation. The implications for prevention and treatment will be highlighted.

This session will showcase cutting-edge research and innovations in cancer science and therapeutic approaches. Participants will discuss the integration of new technologies in enhancing treatment efficacy.

This track will emphasize the importance of integrative methodologies in cancer research, combining insights from various disciplines. Discussions will focus on how these approaches can lead to more effective cancer therapies.

Focusing on the latest strategies in anti-cancer drug discovery, this session will cover novel compounds and their mechanisms of action. Participants will discuss the challenges and successes in bringing new therapies to the clinic.